Clinical Updates | Conference Update Resource List
Did you miss EASL or AASLD 2016? Click HERE to learn about key clinical updates in Hepatitis C presented at recent conferences.
Last Updated on May 17, 2020 by HepFree NYC
Tags: HepCX NewsA network building capacity to prevent, manage and treat hepatitis B and C in NYC
Did you miss EASL or AASLD 2016? Click HERE to learn about key clinical updates in Hepatitis C presented at recent conferences.
Last Updated on May 17, 2020 by HepFree NYC
Tags: HepCX NewsThe new CDC algorithm for testing and treating pregnant women for hepatitis B The PHBPP Perinatal Algorithm has been finalized and is now posted on the Division of Viral Hepatitis webpage. The link is below: https://www.cdc.gov/hepatitis/hbv/perinatalxmtn.htm Here you will find...
We describe the mortality profile of NYC residents with HBV or HCV, emphasizing the contributions of HCC and HIV coinfection.
This report presents an overview of the NYC Health Department’s 2018 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
NYS Hep C 'Baby Boomer' Testing Law Background on the Law Effective January 1, 2014, the NYS Hepatitis C Testing Law. 2171 requires healthcare providers to offer hep C test to baby boomers. The law requires full diagnostic testing for those who screen anti-body positive and ei...
Training Notes…. Document Attachments: Hospital Financial Assistance (Hannah Weinstein) HCC Options (Yvonne Cummings) CBWCHC (Calvin Yu) HepCAP (Paulina Vargas) HepCAP Flyer Federal Poverty Level Info Medicaid Buy In Program (Carol Santangelo) Hepatitis Med Coverage (Adrian...
The Association of Asian Pacific Community Health Organizations (AAPCHO), today launched new a website highlighting stories of Asian Americans and Pacific Islanders (AAPIs) impacted by hepatitis B.The #justB website was created to bring more attention to hepatitis B and the impac...
COVID-19 "Coronavirus" Community & NYC Hep Service Provider Resources
The Medicaid Fee For Service formulary has added Daklinza and Technivie as non-preferred drugs for HCV.